Sugi Predict

Sugi Predict / Compounds / SCHEMBL360294

SCHEMBL360294

SCHEMBL360294

c1ccc(-c2c(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)ccc(N(c3ccccc3)c3ccccc3)c2-c2ccccc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 3/20 0.39
▸ MAPT P10636 3/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ MEN1 O00255 3/20 0.34
▸ KMT2A Q03164 3/20 0.34
▸ ATM Q13315 2/20 0.34
▸ CRHBP P24387 1/20 0.34
▸ CRHR2 Q13324 1/20 0.34
▸ TLR9 Q9NR96 1/20 0.34
▸ APP P05067 1/20 0.33
▸ RXRA P19793 1/20 0.32
▸ RXRB P28702 1/20 0.32
▸ LMNA P02545 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8749954 1.00 L3MBTL1 (0.39) L3MBTL1MAPTALDH1A1KDM4ECYP1A2
SCHEMBL27269782 0.95 ALDH1A1 (0.34) L3MBTL1MAPTALDH1A1KDM4ECYP1A2
SCHEMBL7714905 0.94 ALDH1A1 (0.34) L3MBTL1MAPTALDH1A1KDM4ECYP1A2
Ammonia Solution, Strong SCHEMBL302065 0.93 ALDH1A1 (0.33) L3MBTL1MAPTALDH1A1KDM4ECYP1A2
SCHEMBL27269850 0.91 MAPT (0.37) L3MBTL1MAPTALDH1A1KDM4ECYP1A2
SCHEMBL5817829 0.90 MAPT (0.32) L3MBTL1MAPTALDH1A1KDM4ECYP1A2
SCHEMBL29475171 0.90 ALDH1A1 (0.56) L3MBTL1MAPTALDH1A1KDM4ECYP1A2
SCHEMBL10522612 0.88 ALDH1A1 (0.48) L3MBTL1MAPTALDH1A1KDM4ECYP1A2
SCHEMBL297638 0.88 ALDH1A1 (0.48) L3MBTL1MAPTALDH1A1KDM4ECYP1A2
SCHEMBL28845467 0.87 ALDH1A1 (0.47) L3MBTL1MAPTALDH1A1KDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060255322-A1 Methods and compositions for improved electrophoretic display performance WU ZARNG-ARH G 2006-11-16 — — US claimed
EP-1529242-A2 PROTECTING LAYER WITH ADDITIVES FOR ELECTROPHORETIC DISPLAY, METHOD OF PROVIDING SUCH LAYER, AND ELECTROPHORETIC DISPLAY WITH SUCH A LAYER Sipix Imaging, Inc. (US) 2005-05-11 — — EP claimed
US-20040085619-A1 Novel Methods and compositions for improved electrophoretic display performance SIPIX IMAGING, INC. 2004-05-06 — — US claimed
WO-2004010206-A2 PROTECTING LAYER WITH ADDITIVES FOR ELECTROPHORETIC DISPLAY, METHOD OF PROVIDING SUCH LAYER, AND ELECTROPHORETIC DISPLAY WITH SUCH A LAYER SIPIX IMAGING, INC. (US) 2004-01-29 — — WO claimed
US-12349573-B2 Organic electroluminescent element, method for producing same and display device Konica Minolta, Inc. (JP) 2025-07-01 — — US disclosed
US-20230020129-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, METHOD FOR PRODUCING SAME AND DISPLAY DEVICE Konica Minolta, Inc. (JP) 2023-01-19 — — US disclosed
EP-2315502-B1 Electroluminescent device UDC IRELAND LTD (IE) 2020-10-14 — — EP disclosed
EP-2728639-B1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ITS MANUFACTURING METHOD KONICA MINOLTA INC (JP) 2018-04-18 — — EP disclosed
EP-2265092-B1 Electroluminescent device UDC IRELAND LTD (IE) 2018-03-14 — — EP disclosed
EP-1520450-B1 ELECTROLUMINESCENT DEVICE UDC IRELAND LTD (IE) 2017-08-02 — — EP disclosed
US-9640775-B2 Organic electroluminescence element Konica Minolta, Inc. (JP) 2017-05-02 — — US disclosed
EP-2623508-B1 Iridium complex compound, organic electroluminescent element material, organic electroluminescent element, illumination device and display device KONICA MINOLTA ADVANCED LAYERS (JP) 2016-03-16 — — EP disclosed
US-6451459-B1 DIKETOPYRROLOPYRROLE (DPP) BASED POLYMERS AND COPOLYMERS CIBA SPECIALTY CHEMICALS CORPORATION 2002-09-17 — — US disclosed
EP-1216285-A1 FLUORESCENT MALEIMIDES AND USES THEREOF Ciba SC Holding AG (CH) 2002-06-26 — — EP disclosed
US-20020065422-A1 Fluorescent maleimides and uses thereof KUNIMOTO KAZUHIKO (JP) 2002-05-30 — — US disclosed
US-6258954-B1 ELECTROLUMINESCENCE; DETECTION VOIDS CIBA SPECIALTY CHEMICALS CORP. 2001-07-10 — — US disclosed
EP-1087006-A1 Electroluminescent devices comprising diketopyrrolopyrroles Ciba SC Holding AG (CH) 2001-03-28 — — EP disclosed
WO-2001019939-A1 FLUORESCENT MALEIMIDES AND USES THEREOF CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2001-03-22 — — WO disclosed
EP-1078970-A1 DPP-containing conjugated polymers and electroluminescent devices Ciba SC Holding AG (CH) 2001-02-28 — — EP disclosed
EP-1013740-A2 Electroluminescent material, electroluminescent element and color conversion filter KONICA CORPORATION (JP) 2000-06-28 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020065422-A1 Fluorescent maleimides and uses thereof IK, PAH, MYO1F L3MBTL1 4046/4885MAPT 1437/4885ALDH1A1 286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.